This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Shouyao Holdings (Beijing) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zhenliang Shan: Innovator in Bromine Domain Protein Inhibitors
Introduction
Zhenliang Shan is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of protein inhibitors. His work focuses on innovative solutions for treating diseases mediated by BET proteins.
Latest Patents
Zhenliang Shan holds 1 patent for his invention titled "Crystal form and salt form of bromine domain protein inhibitor and preparation method therefor." This patent describes a crystal form and salt form of a bromine domain protein inhibitor, represented by a specific formula. The invention also outlines a preparation method and the use of these forms in developing drugs aimed at treating diseases associated with BET proteins.
Career Highlights
Throughout his career, Zhenliang Shan has worked with prominent companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Shouyao Holdings (Beijing) Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Zhenliang Shan has collaborated with various professionals in his field, including his coworker Yingya Zhang. These collaborations have likely enhanced his research and development efforts, leading to advancements in pharmaceutical technologies.
Conclusion
Zhenliang Shan is a distinguished inventor whose work in bromine domain protein inhibitors has the potential to impact the treatment of various diseases. His contributions to the pharmaceutical industry reflect his commitment to innovation and excellence.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile